New one-dose treatment edits a gene in the liver, disabling the ANGPTL3 protein and significantly lowers cholesterol.

The FDA has approved Fesilty (fibrinogen, human-chmt) for the treatment of acute bleeding episodes in pediatric and adult patients with congenital fibrinogen deficiency (CFD), including hypo- or ...

To better support their employee base and help cut costs, healthcare benefit platform Angle Health partnered with specialty ...

Chimeric antigen receptor (CAR) T-cell therapy-associated immune-related adverse events (CirAEs) were associated with a high ...

High-priced treatments, administered in expensive facilities, are becoming one of the largest cost drivers within ...

Researchers from the Wilmer Eye Institute, Johns Hopkins Medicine Center for Nanomedicine—which designs nanotechnology-based ...

MyMichigan Medical Center Gladwin has added four new infusion therapy chairs to enhance patient comfort, funded by a $24,000 donation from the MyMichigan Health Foundation.

Serenity Mental Health Centers, a leader in psychiatric care and one of the fastest growing mental health providers in the ...

Key points A 75-year-old woman presented to the emergency department with acute confusion and lethargy on the third day of ...

Bringing regenerative medicine, longevity science, and advanced mental-health therapies to the Great Lakes Bay Region ...